Hyperkinesis [clinicaltrials_resource:4e1780aa0936ea8264687505f74f088a]
condition [clinicaltrials_vocabulary:condition]
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) [clinicaltrials:NCT00000388]Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00001206]Assessment of Attentional Functioning in Children With HIV-1 Infection [clinicaltrials:NCT00001497]Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation [clinicaltrials:NCT00001915]Brain Imaging in Children With AD/HD [clinicaltrials:NCT00008892]Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00011466]Treatment of Youth With ADHD and Anxiety [clinicaltrials:NCT00012584]Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [clinicaltrials:NCT00025779]Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers [clinicaltrials:NCT00026546]Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [clinicaltrials:NCT00031395]Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00046059]Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [clinicaltrials:NCT00048360]Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00050050]Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00050622]Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00051337]Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00056888]Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I [clinicaltrials:NCT00071656]Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00100295]Brain Changes in Children and Adolescents With Behavioral Problems [clinicaltrials:NCT00104039]Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00116259]clinicaltrials:NCT00118911clinicaltrials:NCT00142961Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00143767]Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning [clinicaltrials:NCT00143832]Efficacy and Safety of SPD465 in Adults With ADHD [clinicaltrials:NCT00150579]Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [clinicaltrials:NCT00150592]Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [clinicaltrials:NCT00150618]Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials [clinicaltrials:NCT00151957]Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD [clinicaltrials:NCT00151970]Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00151996]Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 [clinicaltrials:NCT00152009]Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. [clinicaltrials:NCT00152022]Safety of SPD465 in Treating Adults With ADHD. [clinicaltrials:NCT00152035]Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD [clinicaltrials:NCT00152750]Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00161161]Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar [clinicaltrials:NCT00174226]clinicaltrials:NCT00178503Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings [clinicaltrials:NCT00179894]Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS) [clinicaltrials:NCT00181857]
condition browse [clinicaltrials_vocabulary:condition-browse]
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) [clinicaltrials:NCT00000388]Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00001206]Assessment of Attentional Functioning in Children With HIV-1 Infection [clinicaltrials:NCT00001497]Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation [clinicaltrials:NCT00001915]Brain Imaging in Children With AD/HD [clinicaltrials:NCT00008892]Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00011466]Treatment of Youth With ADHD and Anxiety [clinicaltrials:NCT00012584]Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) [clinicaltrials:NCT00018863]Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders [clinicaltrials:NCT00025779]Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers [clinicaltrials:NCT00026546]Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children [clinicaltrials:NCT00031395]Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00046059]Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [clinicaltrials:NCT00048360]Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00050050]Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00050622]Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00051337]Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders [clinicaltrials:NCT00056888]Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I [clinicaltrials:NCT00071656]Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00100295]Brain Changes in Children and Adolescents With Behavioral Problems [clinicaltrials:NCT00104039]Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00116259]clinicaltrials:NCT00118911clinicaltrials:NCT00142961Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00143767]Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning [clinicaltrials:NCT00143832]Efficacy and Safety of SPD465 in Adults With ADHD [clinicaltrials:NCT00150579]Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 [clinicaltrials:NCT00150592]Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 [clinicaltrials:NCT00150618]Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials [clinicaltrials:NCT00151957]Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD [clinicaltrials:NCT00151970]Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) [clinicaltrials:NCT00151996]Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 [clinicaltrials:NCT00152009]Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. [clinicaltrials:NCT00152022]Safety of SPD465 in Treating Adults With ADHD. [clinicaltrials:NCT00152035]Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD [clinicaltrials:NCT00152750]Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder [clinicaltrials:NCT00161161]Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar [clinicaltrials:NCT00174226]clinicaltrials:NCT00178503Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings [clinicaltrials:NCT00179894]Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS) [clinicaltrials:NCT00181857]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Hyperkinesis [clinicaltrials_resource:4e1780aa0936ea8264687505f74f088a]
Bio2RDF identifier
4e1780aa0936ea8264687505f74f088a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4e1780aa0936ea8264687505f74f088a
identifier
clinicaltrials_resource:4e1780aa0936ea8264687505f74f088a
title
Hyperkinesis
@en
type
label
Hyperkinesis [clinicaltrials_resource:4e1780aa0936ea8264687505f74f088a]
@en
Hyperkinesis